On Friday, Shares of Ambev S.A. (NYSE:ABEV), gained 2.93% to $6.67.
Ambev, declared its results for the 2015 first quarter. The following operating and financial information, unless otherwise indicated, is presented in nominal Reais and prepared according to International Financial Reporting Standards (IFRS), and should be read together with our quarterly financial information for the three-month period ended March 31, 2015 filed with the CVM and presented to the SEC.
Operating and Financial Highlights
Net revenues raised 14.5% in the 1Q15, driven by solid top line growth in all of its operations (Brazil +10.7%, Central America and the Caribbean +26.4%, LAS +27.8% and Canada +6.0%). This performance is explained by (i) a volume growth of 0.4%, with positive contributions in Brazil Beer (+0.4%), Central America and the Caribbean (+22.6%) and Canada (+1.4%), partially offset by a decline in Brazil CSD & NANC (-2.2%) and LAS (-1.4%); coupled with (ii) Net Revenue per hectoliter (NR/hl) enhance of 14.0%, driven by its revenue administration initiatives, the benefit of premium mix and the raised weight of direct distribution in Brazil.
Company’s COGS raised 15.1%, whereas on a per hectoliter basis, costs raised 14.6%, influenced by inflationary pressures in Brazil and Argentina, unfavorable currency hedges, product mix and higher depreciation, partially offset by the benefit of procurement savings initiatives and better commodities hedges.
Ambev S.A., through its auxiliaries, produces, distributes, and sells beer, draft beer, soft drinks, other non-alcoholic beverages, malt, and food in the Americas. The company operates through Latin America North, Latin America South, and Canada segments. It offers beers primarily under Skol, Brahma, Antarctica brands, Brahva, Brahva Beats, Brahva Light, Extra, Budweiser, Becks, Corona & Stella Artois, Presidente, Brahma Light, President Light, Bohemia, The One, Corona, Stella Artois, Quilmes Cristal, Paceña, Taquiña, Huari, Becker, Báltica, Pilsen, Patricia, and Bud Light, in addition to Labatt Blue, Alexander Keith’s, Stella Artois, and Kokanee brands.
Shares of Vipshop Holdings Limited (NYSE:VIPS), inclined 2.12% to $27.90, during its last trading session.
Vipshop Holdings, declared that it plans to release its first quarter 2015 financial results on Wednesday, May 13, 2015 after market close. The Company will hold a conference call on Thursday, May 14, 2015 at 8:00 am Eastern Time or 8:00 pm Beijing Time to talk about the financial results.
Vipshop Holdings Limited, through its auxiliaries, operates as an online discount retailer for various brands in the People’s Republic of China. It offers a range of branded products, counting apparel for women, men, and children; fashion goods; cosmetics; home goods and other lifestyle products; footwear; sportswear and sporting goods; luxury goods; and gifts and miscellaneous products.
At the end of Friday’s trade, Shares of Rite Aid Corporation (NYSE:RAD), gained 1.40% to $7.98.
Rite Aid Corporation, declared that RediClinic, one of the Company’s wholly owned auxiliaries and a leading operator of convenient care clinics, and MultiCare Health System, a leading, not-for-profit health care organization that offers a comprehensive network of services across the Puget Sound region, have formed a joint venture to expand access to healthcare services in the greater Seattle area. Through the joint venture, RediClinic and MultiCare will collaborate to operate 11 RediClinics inside select Rite Aid pharmacies. MultiCare presently operates a convenient care clinic inside the Rite Aid pharmacy located at 5700 100th Street SW in Lakewood.
Rite Aid Executive Vice President of Pharmacy Robert Thompson, RediClinic CEO Web Golinkin and MultiCare Health System President and CEO Bill Robertson will officially declare the joint venture and mark the first of 11 clinic openings with a ribbon-cutting recently at 10 a.m. PT at the Rite Aid pharmacy located at 15100 S.E. 38th Street in Bellevue, Wash.
Rite Aid Corporation, through its auxiliaries, operates a chain of retail drugstores in the United States. The company sells prescription drugs and a range of other merchandise, counting over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
Finally, Corning Inc. (NYSE:GLW), ended its last trade with 0.52% gain, and closed at $21.15.
Corning Incorporated, declared that on May 5, 2015 it priced $375 million aggregate principal amount of senior unsecured notes that mature on May 8, 2018 at a coupon of 1.500% and $375 million aggregate principal amount of senior unsecured notes that mature on May 15, 2022 at a coupon of 2.900%. Subject to customary closing conditions, the sales are predictable to close on May 8, 2015. The net proceeds of the offerings will be used for general corporate purposes.
Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated served as joint book-running managers and underwriters for the offering.
Corning Incorporated manufactures and sells specialty glasses, ceramics, and related materials worldwide. The company operates through five segments: Display Technologies, Optical Communications, Environmental Technologies, Specialty Materials, and Life Sciences. The Display Technologies segment manufactures glass substrates for active matrix liquid crystal displays (LCDs) that are used primarily in LCD televisions, notebook computers, and flat panel desktop monitors.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
